[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
IJRR Information::
For Authors::
For Reviewers::
Subscription::
News & Events::
Web Mail::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
ISSN
Hard Copy 2322-3243
Online 2345-4229
..
Online Submission
Now you can send your articles to IJRR office using the article submission system.
..

AWT IMAGE

AWT IMAGE

:: Volume 1, Issue 1 (6-2003) ::
Int J Radiat Res 2003, 1(1): 29-35 Back to browse issues page
Potent radioprotective effect of therapeutic doses of ranitidine and famotidine against gamma-rays induced micronuclei in vivo
H. Mozdarani , M. Shahidi
, Mozdarah@modares.ac.ir
Abstract:   (28207 Views)

Background: Previous investigations have revealed, cimetidine, a histamine H2-receptor antagonist, show radioprotective effects against gamma- and neutron-induced micronuclei in bone marrow erythrocytes. In this study, the anticlastogenic effects of famotidine and ranitidine, which act similar to cimetidine as histamine H2-receptor antagonists, was investigated.

Materials and Methods : Balb/c male mice were injected i.p. with various doses of famotidine and ranitidine two hours before 2 Gy gamma irradiation. Frequency of micronuclei was determined in bone marrow erythrocytes following each treatment.

Results: The results indicated that gamma irradiation alone can cause a high frequency of micronuclei formation and decrease cell proliferation ratio. Pre-irradiation injection of famotidine and ranitidine, of various doses, effectively reduced the number of micronucleated polychromatic erythrocytes (MnPCEs), yet has no effect on cell proliferation ratio (PCEs/PCEs+NCEs). In fact, these two drugs reduce the clastogenic effects of gamma rays, while they are ineffective against the cytotoxic properties of gamma rays.

Conclusion: The dose reduction factor (DRF) calculated, shows a DRF=2 for famotidine and a DRF=1.8 for ranitidine which is indicative of a high radioprotective property of these drugs. The mechanism in which these drugs reduce clastogenic effect of gamma radiation is not fully understood. It might be due to their antioxidant and free radical-scavenging properties. Iran . J. Radiat. Res. 2003 1(1): 29 - 35.

Keywords: Famotidine, ranitidine, gamma rays, micronuclei, mouse bone marrow erythrocytes.
Full-Text [PDF 99 kb]   (3540 Downloads)    
Type of Study: Original Research | Subject: Radiation Biology
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

H. Mozdarani, M. Shahidi. Potent radioprotective effect of therapeutic doses of ranitidine and famotidine against gamma-rays induced micronuclei in vivo. Int J Radiat Res 2003; 1 (1) :29-35
URL: http://ijrr.com/article-1-5-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 1, Issue 1 (6-2003) Back to browse issues page
International Journal of Radiation Research
Persian site map - English site map - Created in 0.06 seconds with 50 queries by YEKTAWEB 4645